TNF and soft tissue sarcoma: Therefore, ILP programs using melphalan alone have been abandoned for treating unresectable soft-tissue sarcomas.17 The application of tumor necrosis factor-alpha (TNF)18 has changed this situation dramatically, because very large tumors are now seen to respond very well.